Tag Archives: stem cell hair treatment

Biostem Seeks to Expand Its Stem Cell Hair Loss Products Worldwide

Biostem Seeks to Expand Its Stem Cell Hair Loss Products Worldwide

Biostem U.S., which describes itself as a “technology licensing company” with hair regrowth treatment using using human stem cells, is seeking to expand its operations worldwide. The company, a NEvada corporation based in Clearwater, FLorida, recently announced the change of its stock symbol to HAIR. The company offers hair growth treatments that feature a combination of Platelet Rich Plasma (PRP) injections, the user of low level lasers, nutritional supplements and other hair products to stimulate new hair growth. The company is hoping to license its technology to private clinics around the world. Its first clinic outside of the Clearwater area is in Ohio.

Biostem was founded by two hair restoration doctors, Dr. John Satino and board-certified Medical Director Dr. Michael Markou, who work out of the Hair and Scalp Clinics in Clearwater, Florida.

It appears that the technique used by Dr. Satino and Dr. Markou is a variation on a technique used by some other hair restoration doctors around the world, which is to gently “wound” or irritate the scalp and then use injections of concentrated growth factors, taken from Platelet Rich Plasma, to stimulate hair follicle regeneration. Recent research has show that the “healing” process in skin seems to have this stimulating effect. Dr. Satino and Dr. Markou use special CO2 lasers to assist them in the gentle wounding of the scalp. They follow up the PRP process with other proven hair growth treatments, including low level lasers and nutritional supplements.

In addition to patients suffering from male pattern baldness, Dr. Satino and Markou have also used their techniques for patients suffering from alopecia areata and female hair loss.

Similar Posts:

RepliCel Now Accepting Applications for Upcoming Clinical Trials of Hair Cloning Technology

RepliCel™ Life Sciences, based in Vancouver, British Columbia, is currently accepting the names of people interested in maybe participating in the next round of its clinical trials of its new hair cloning treatment. Its current Phase I/IIa clinical trials, being conducted in Georgia, are scheduled to end in April 2012.

Replical’s hair regeneration technology involves the harvesting and multiplication of what are called dermal sheath cup (DSC) cells located in a “bulb” at the base of the hair follicle.

In laboratory studies, RepliCel™ scientists have found that DSC cells both stimulate the development of mature hair follicles and the creation of new ones. The scientists discovered that the DSC cells are capable of actually regrowing the dermal papilla and hair follicles themselves.

The way the treatment works is this. Trained technicians harvest DSC cells at locations in the base of the neck, where they are plentiful. These harvested DSC cells are then placed in a special nutrient medium in a laboratory where they multiply.

Once there are a sufficient number of DSC cells taken from a patient’s own neck hairs, the new cells are injected directly into the scalp where hair loss has occurred. Like reseeding a lawn, the DSC cells “migrate” to hair papilla that already exist and effect an regenerative transformation. They also create brand-new hair follicles.

Most importantly, the harvested DSC cells are taken from hair follicles, at the base of the head near the neck, that are not as sensitive to male sex hormones (androgens) which, scientists believe, are what cause the hair follicle miniaturization that makes hair loss happen in the first place.

Also, because the DSC cells come from the patient’s own body, rejection of the cells is far less likely.

RepliCel™ is now accepting queries from individuals who might be interested in participating in its new round of clinical trials. If you’d like more information about possibly participating in its new Phase I/IIa clinical trial of its hair regeneration technology, fill in the form below:

RepliCel Now Accepting Applications for Upcoming Clinical Trials of Hair Cloning Technology

RepliCel™ Life Sciences, based in Vancouver, British Columbia, is currently accepting the names of people interested in maybe participating in the next round of its clinical trials of its new hair cloning treatment. Its current Phase I/IIa clinical trials, being conducted in Georgia, are scheduled to end in April 2012.

Replical’s hair regeneration technology involves the harvesting and multiplication of what are called dermal sheath cup (DSC) cells located in a “bulb” at the base of the hair follicle.

In laboratory studies, RepliCel™ scientists have found that DSC cells both stimulate the development of mature hair follicles and the creation of new ones. The scientists discovered that the DSC cells are capable of actually regrowing the dermal papilla and hair follicles themselves.

The way the treatment works is this. Trained technicians harvest DSC cells at locations in the base of the neck, where they are plentiful. These harvested DSC cells are then placed in a special nutrient medium in a laboratory where they multiply.

Once there are a sufficient number of DSC cells taken from a patient’s own neck hairs, the new cells are injected directly into the scalp where hair loss has occurred. Like reseeding a lawn, the DSC cells “migrate” to hair papilla that already exist and effect an regenerative transformation. They also create brand-new hair follicles.

Most importantly, the harvested DSC cells are taken from hair follicles, at the base of the head near the neck, that are not as sensitive to male sex hormones (androgens) which, scientists believe, are what cause the hair follicle miniaturization that makes hair loss happen in the first place.

Also, because the DSC cells come from the patient’s own body, rejection of the cells is far less likely.

RepliCel™ is now accepting queries from individuals who might be interested in participating in its new round of clinical trials.

Similar Posts: